Phenomenex was founded in 1982 by architect and businessman Fasha Mahjoor, originally starting from humble beginnings in a garage in Torrance, California. Over nearly four decades, it has grown into a global technology leader renowned for its innovations in analytical chemistry, specifically in chromatography products that help separate and purify chemicals across various industries.

The company specializes in developing and manufacturing chromatography products used in the separation, analysis, and purification of pharmaceuticals, biopharmaceuticals, chemicals, and other substances. Its technologies support applications in drug discovery, pharmaceutical development, food safety, environmental analysis, forensic investigations, and cancer research, among others.

Phenomenex’s core technologies are integral in testing a vast array of everyday products and substances, ensuring safety, quality, and consistency. This includes their use in pharmaceutical manufacturing to produce life-saving medications, forensic labs to solve crimes, and food testing to prevent harmful chemical exposure.

The company is distinguished by its commitment to innovation, having received the prestigious R&D 100 Award eleven times. This recognition highlights Phenomenex’s leadership in developing advanced separation devices, sample preparation consumables, and gas chromatography products used widely in life sciences, environmental sectors, petrochemical industries, and healthcare.

Phenomenex’s growth and success are attributed to strategic investments in research and development, nurturing human capital, and maintaining a unique, service-driven culture. In November 2017, Phenomenex joined the Danaher Corporation, expanding its global reach and resources to further its mission of accelerating scientific progress and improving global health and wellbeing.